Medical Polymer Market by Type (Medical Plastics, Medical Elastomers), Application (Medical Disposables, Medical Instruments and Devices, Prosthetics, Diagnostics Instruments and Tools), Manufacturing Technology, and Region - Global Forecast to 2030

icon1
USD 66.3 BN
MARKET SIZE, 2030
icon2
CAGR 8.2%
(2025-2030)
icon3
320
REPORT PAGES
icon4
260
MARKET TABLES

OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The medical polymer market is expected to reach USD 66.3 billion by 2030, up from USD 44.7 billion in 2025, growing at a CAGR of 8.2% from 2025 to 2030. The market's growth is fueled by increasing demand for advanced medical devices, minimally invasive procedures, biocompatible materials, and expanding healthcare infrastructure.

KEY TAKEAWAYS

  • The medical polymer market comprises medical plastics and medical elastomers.
  • Key manufacturing technologies include extrusion tubing, compression molding, injection molding, and other manufacturing technologies.
  • Key applications of medical polymer span medical disposables, medical instruments & devices, prosthetics, diagnostic instruments & tools, and others.
  • The medical polymer market includes Europe, North America, Asia Pacific, South America, the Middle East, and Africa. Asia Pacific is the largest market for medical polymers due to improvements in healthcare infrastructure, higher demand for medical devices, and increased investments in production capacity. A growing population, urbanization, and a rising middle class in countries like China, India, and Southeast Asian nations are driving the significant increase in healthcare spending and access to specialized medical treatments.
  • Major market players have adopted both organic and inorganic strategies, including partnerships and investments. For instance, SABIC (Saudi Arabia) and Covestro AG (Germany) have entered into a number of agreements and partnerships to cater to the growing demand for medical polymer across innovative applications.

The medical polymer market is experiencing steady growth, driven by increasing demand for advanced medical devices, a rising elderly population, and the growing adoption of minimally invasive procedures. Global expansion in this market is further supported by ongoing technological advancements in the development of biocompatible and high-performance materials, expanding healthcare infrastructure, and rising awareness about healthcare quality.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The influence on consumer enterprises derives from prevailing customer trends or disruptions. 'Hotbets' refer to clients of medical polymer manufacturers, and their target applications are also within the scope of these manufacturers. Changes, whether in evolving trends or disruptions, will impact the revenues of end users. This revenue impact on end users will, in turn, affect the revenues of 'hotbets', thereby further influencing the revenue of medical polymer manufacturers.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing demand for biocompatible materials
  • Growing aging population globally
RESTRAINTS
Impact
Level
  • Environmental sustainability concerns
  • High competition from alternative materials
OPPORTUNITIES
Impact
Level
  • Demand for minimally invasive devices
  • Growth in regenerative medicine
CHALLENGES
Impact
Level
  • Long-term durability and controlling degradation
  • Cost constraints for novel materials

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing demand for biocompatible materials

The medical polymer market is fueled by a rise in the demand for biocompatible materials, which are materials that interact safely with the human body, and do not cause adverse effects. These materials can be found in numerous capacities such as implants, surgical tools, catheters, and drug delivery systems, where safety and compatibility are critical components of their use. As monitors of one's health become more personalized and less invasive, the demand for reliable, non-toxic, durable polymers will continue to grow, enhancing innovation and increased use of advanced medical polymers, helping the market as a whole to continue its growth globally.

Restraint: Environmental sustainability concerns

Environmental sustainability concerns restrain the medical polymer market because many polymers are non-biodegradable and contribute to medical waste, posing disposal and ecological challenges. Strict regulations on plastic use and increasing demand for eco-friendly alternatives add pressure on manufacturers. Developing sustainable, biocompatible polymers often involves higher costs and complex processes, limiting rapid adoption and slowing overall market growth despite rising healthcare needs.

Opportunity: Demand for minimally invasive devices

A growing need for minimally invasive devices creates a substantial opportunity for the medical polymer market, given that these procedures utilize lightweight, flexible, and durable materials. Medical polymers facilitate the design of catheters, stents, and surgical devices that improve patient recovery, shorten hospital stays, and improve accuracy for the procedure. The growing adoption of minimally invasive procedures for healthcare providers leads to a growing demand for polymetric materials thus fuieling creativity and increasing opportunities for market expansion globally.

Challenge: Long-term durability and controlling degradation

Long-term durability and degradation control pose a significant challenge for medical polymers because devices like prosthetics, implants, and drug delivery systems need to maintain their structural integrity and functionality when used inside the human body for extended periods. Exposure to bodily fluids, mechanical stresses, and chemical reactions can cause premature wear or failure. Managing performance while minimizing material degradation is an inherently technical challenge, which increases development costs and limits the longevity and reliability of products made from medical polymers.

Medical Polymer Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Supplies biocompatible polymers and polyurethane systems for medical devices, prosthetics, and wound care High durability, chemical resistance, safe skin contact, and long-term performance
Provides specialty thermoplastics (PEI, PC, PP) for surgical instruments, drug delivery devices, and trays Lightweight, sterilization resistance, superior toughness, and cost-effective manufacturing
Offers high-performance thermoplastics (POM, PEEK, UHMW-PE) for orthopedic implants and dental devices High wear resistance, excellent dimensional stability, and lightweight metal alternatives
Develops medical-grade polycarbonate and TPU for infusion sets, dialysis equipment, and surgical tools Transparency, impact strength, sterilizability, and patient safety compliance
Manufactures bioresorbable polymers (PLGA, PLA) for implants, stents, and controlled drug release systems Biodegradability, reduced need for secondary surgery, and precise therapeutic release

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The medical polymer market ecosystem consists of raw material suppliers (DSM-Firmenich, Eastman Chemical Company), manufacturers (BASF, SABIC, Covestro AG, Celanese Corporation), and end users (Medtronic, GE HealthCare). Raw materials include monomers, such as ethylene oxide and propylene oxide, as well as various petrochemical-derived compounds used in polymer synthesis. End users drive demand for product development, quality standards, and pricing strategies. Collaboration across the value chain is key to innovation and market growth.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Medical Polymer Market, By Type

The medical plastics segment is expected to be the largest in the medical polymer industry because of their affordability, versatility, and widespread use in medical devices. Medical plastics are biocompatible, chemically resistant, and capable of withstanding sterilization processes, which allows manufacturers to produce syringes, catheters, IV bags, surgical equipment, devices, and analytical and diagnostic tools. Medical plastics are lightweight, can be molded into various shapes and complex designs, and are rigid yet safe for patients. The healthcare industry continues to favor the adoption of single-use and disposable medical devices to reduce cross-contamination and healthcare-associated infections (HCAIs), ensuring that the demand for medical plastics will keep growing. Advancements in polymer formulations, such as antimicrobial or bioresorbable plastics, are further enhancing their functionality. In terms of performance, usability, and compliance with healthcare regulations, medical plastics are leading as the most common products within the medical polymer sector.

Medical Polymer Market, By Manufacturing Technology

Extrusion tubing is the largest manufacturing technology in the medical polymer market owing to its accuracy, consistency, and adaptability in manufacturing components that are critical to the function of a medical device. The extrusion process allows for continuous processing of smooth, dimensionally accurate tubing used in catheters, intravenous lines, hemodialysis, and infusion devices. All of these devices are critical to patient safety and assuring that a medical device functions reliably. Compatibility with many lower cost polymers such as PVC, polyethylene, polyurethane, and silicone, makes extrusion appropriate for both single and multilayer tubing designs which can provide more sophisticated performance properties. The low-cost extrusion process is suitable for scaling up production and is ready for automation. This provides competitive incentives especially with the increasing trend of medical device products to be more sophisticated, less invasive and single-use.

Medical Polymer Market, By Application

Medical instruments & devices lead the medical polymer industry because of their many uses and applications in healthcare, such as surgical instruments, catheters, implants, diagnostic devices, tubing, and equipment housing. The main factors driving demand for these materials are the need for durability, precision tolerances, and biocompatibility, along with the benefits of miniaturization and lightweight designs for vaccine distribution. The rise in surgical procedures, diagnostic testing, and the trend toward disposable devices has boosted the demand for polymers. Advances in polymer science have opened up possibilities for drug delivery, antimicrobial surfaces, and increased flexibility, which strengthen the market’s leading position and will continue to promote growth and innovation.

REGION

North America to be fastest-growing region in global medical polymer market during forecast period

The medical polymer market in North America is fueled by rising demand for advanced medical devices, an aging population requiring implants and prosthetics, continuous R&D investments, and strict regulatory standards. Additionally, the growing use of minimally invasive surgeries, biocompatible materials, and expanded healthcare infrastructure further drives market adoption across various medical applications.

Medical Polymer Market: COMPANY EVALUATION MATRIX

In the medical polymer market matrix, BASF (Star) leads with a strong market share and extensive product range due to its wide portfolio of high-performance, biocompatible polymers designed for medical applications. Solvay (Emerging Leader) has advanced specialty polymers that provide high performance, biocompatibility, and durability for next-generation medical devices. While BASF maintains dominance through scale and a diverse product lineup, Solvay shows significant potential to move into the leaders’ quadrant as demand for high-performance polymers continues to grow.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 41.4 Billion
Market Forecast in 2030 (value) USD 66.3 Billion
Growth Rate CAGR of 8.2% from 2025-2030
Years Considered 2022-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Million/Billion), Volume (Kiloton)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Type: Medical Plastics and Medical Elastomers
  • By Manufacturing Technology:
    • Extrusion Tubing
    • Compression Moulding
    • Injection Moulding
    • and Other Manufacturing Technologies
  • By Application:
    • Medical Disposables
    • Medical Instruments & Devices
    • Prosthetics
    • Diagnostic Instruments & Tools
    • and Other Applications
Regions Covered North America, Asia Pacific, Europe, South America, Middle East & Africa

WHAT IS IN IT FOR YOU: Medical Polymer Market REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Medical Device OEM
  • Benchmarking of polymer usage across implants, surgical tools, and diagnostics
  • Evaluation of performance vs. regulatory compliance
  • Supply chain ecosystem and sourcing strategy analysis
  • Identify qualified material partners
  • Detect cost-saving and efficiency opportunities
  • Highlight innovation gaps in material portfolios
Polymer Manufacturer
  • Market adoption benchmarking across regions & applications
  • Application roadmap for minimally invasive and wearable devices
  • Switching cost analysis vs. metals and ceramics
  • Insights on demand growth in high-potential segments
  • Support product targeting and faster adoption
  • Minimize substitution risks through innovation
Hospital & Healthcare Providers
  • Technical and economic assessment of disposable vs reusable polymer devices
  • Forecast adoption of biocompatible and antimicrobial polymers
  • Lifecycle cost and safety benchmarking
  • Improve procurement efficiency
  • Reduce infection risks with advanced materials
  • Strengthen transition toward sustainable healthcare solutions
Raw Material Supplier
  • Global & regional production capacity benchmarking
  • Mapping certifications and compliance with FDA/EMA/ISO
  • Profiling OEMs and contract manufacturers by demand
  • Strengthen forward integration
  • Secure long-term contracts with high-demand OEMs
  • Identify supply-demand gaps for competitive edge
Pharma & Biotech Companies
  • Patent and IP mapping for drug-delivery polymers & biodegradable materials
  • Benchmarking adoption in packaging and controlled-release systems
  • Assessment of polymer integration in new therapies
  • Support backward integration into drug delivery innovation
  • Identify future therapies requiring polymer advancements
  • Gain early-mover advantage in biocompatible packaging

RECENT DEVELOPMENTS

  • March 2024 : SABIC, one of the world's largest chemical companies, explored new market opportunities to recycle medical plastics back into the medical materials stream with the dialysis department at Jessa Hospital, one of the largest non-university medical clusters in Limburg, Flanders, Belgium. As a pilot proof-of-concept, used medical plastic from Jessa’s hospitals was processed through an advanced recycling process into pyrolysis oil, which provided circular feedstock for SABIC to make TRUCIRCLE polymers. Each product was manufactured to medical-grade specifications and had equal or superior performance, purity, and physiological safety compared to virgin-based medical grade polymers.
  • October 2023 : Covestro installed the first mechanical recycling (MCR) compounding line dedicated to polycarbonates in operation at its integrated site in Shanghai, China. The compounding line will produce more than 25,000 tons of polycarbonates, and blends containing mechanically recycled materials, every year in response to sustainability commitments, especially for post-consumer-recycled (PCR) plastics used in electrical/electronic products, automotive, healthcare, and consumer goods applications.
  • October 2023 : Covestro increased production capacities associated to thermoplastic polyurethane (TPU) films in the Platilon product range, and associated infrastructure and logistics in Bomlitz, Lower Saxony, Germany.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
27
2
RESEARCH METHODOLOGY
 
 
 
31
3
EXECUTIVE SUMMARY
 
 
 
41
4
PREMIUM INSIGHTS
 
 
 
45
5
MARKET OVERVIEW
Biocompatible materials surge amid aging population and tech advances, despite regulatory and cost hurdles.
 
 
 
48
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
Increasing demand for biocompatible materials
 
 
 
 
5.2.1.2
Surge in global aging population
 
 
 
 
5.2.1.3
Advancements in medical technology
 
 
 
 
5.2.1.4
Rise in chronic diseases
 
 
 
 
5.2.1.5
Regulatory support for medical-grade materials
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
Regulatory complexities and approvals
 
 
 
 
5.2.2.2
High competition from alternative materials
 
 
 
 
5.2.2.3
Environmental sustainability concerns
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
Growth in regenerative medicine
 
 
 
 
5.2.3.2
Demand for minimally invasive devices
 
 
 
 
5.2.3.3
Advancements in biodegradable polymers
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
Cost constraints for novel materials
 
 
 
 
5.2.4.2
Long-term durability and degradation control
 
 
5.3
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.3.1
THREAT FROM NEW ENTRANTS
 
 
 
 
5.3.2
THREAT OF SUBSTITUTES
 
 
 
 
5.3.3
BARGAINING POWER OF BUYERS
 
 
 
 
5.3.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.3.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.4
MACROECONOMIC INDICATORS
 
 
 
 
 
5.4.1
GLOBAL GDP TRENDS
 
 
6
INDUSTRY TRENDS
Biocompatible polymers and regulatory shifts redefine medical device manufacturing and supply chains.
 
 
 
60
 
6.1
INTRODUCTION
 
 
 
 
6.2
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
6.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
6.2.2
BUYING CRITERIA
 
 
 
6.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
6.3.1
RAW MATERIAL SUPPLIERS
 
 
 
 
6.3.2
MANUFACTURERS
 
 
 
 
6.3.3
DISTRIBUTORS
 
 
 
 
6.3.4
END CONSUMERS
 
 
 
6.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
6.5
CASE STUDY ANALYSIS
 
 
 
 
 
6.5.1
EVONIK INDUSTRIES PROVIDES MEDICAL POLYMERS TO JENACELL GMBH FOR WOUND DRESSINGS, IMPLANTABLE MATERIALS, AND DRUG DELIVERY SYSTEMS
 
 
 
 
6.5.2
ENSINGER OFFERS HIGH-PERFORMANCE, MEDICAL-GRADE POLYMERS FOR HIGH-FREQUENCY SURGERY
 
 
 
6.6
REGULATORY LANDSCAPE
 
 
 
 
6.7
TECHNOLOGY ANALYSIS
 
 
 
 
 
6.7.1
KEY TECHNOLOGY
 
 
 
 
 
6.7.1.1
Biocompatible polymers
 
 
 
 
6.7.1.2
Thermoplastic elastomers
 
 
 
6.7.2
COMPLEMENTARY TECHNOLOGY
 
 
 
 
 
6.7.2.1
Thermoplastic elastomers
 
 
 
 
6.7.2.2
Surface modification techniques
 
 
6.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
6.9
TRADE ANALYSIS
 
 
 
 
 
 
6.9.1
IMPORT SCENARIO
 
 
 
 
6.9.2
EXPORT SCENARIO
 
 
 
6.10
KEY CONFERENCES & EVENTS, 2025−2026
 
 
 
 
6.11
PRICING ANALYSIS
 
 
 
 
 
 
6.11.1
AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024
 
 
 
 
6.11.2
AVERAGE SELLING PRICE TREND, BY APPLICATION, 2022–2024
 
 
 
 
6.11.3
AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, BY APPLICATION, 2024
 
 
 
6.12
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
6.13
PATENT ANALYSIS
 
 
 
 
 
 
6.13.1
METHODOLOGY
 
 
 
 
6.13.2
PATENTS GRANTED WORLDWIDE, 2015–2024
 
 
 
 
6.13.3
PUBLICATION TRENDS
 
 
 
 
6.13.4
INSIGHTS
 
 
 
 
6.13.5
LEGAL STATUS OF PATENTS
 
 
 
 
6.13.6
JURISDICTION ANALYSIS
 
 
 
 
6.13.7
TOP APPLICANTS
 
 
 
6.14
IMPACT OF AI/GEN AI ON MEDICAL POLYMER MARKET
 
 
 
 
 
6.15
IMPACT OF 2025 US TARIFF ON MEDICAL POLYMER MARKET
 
 
 
 
 
 
6.15.1
INTRODUCTION
 
 
 
 
6.15.2
KEY TARIFF RATES
 
 
 
 
6.15.3
PRICE IMPACT ANALYSIS
 
 
 
 
6.15.4
IMPACT ON KEY COUNTRIES/REGIONS
 
 
 
 
 
6.15.4.1
North America
 
 
 
 
6.15.4.2
Europe
 
 
 
 
6.15.4.3
Asia Pacific
 
 
 
6.15.5
IMPACT ON END-USE INDUSTRIES
 
 
7
MEDICAL POLYMER MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Kilotons | 4 Data Tables
 
 
 
86
 
7.1
INTRODUCTION
 
 
 
 
7.2
MEDICAL PLASTICS
 
 
 
 
 
7.2.1
ADVANCEMENTS IN MATERIAL SCIENCE AND MANUFACTURING TECHNOLOGIES TO DRIVE MARKET
 
 
 
 
7.2.2
POLYPROPYLENE
 
 
 
 
7.2.3
POLYVINYL CHLORIDE
 
 
 
 
7.2.4
POLYETHYLENE
 
 
 
 
7.2.5
POLYSTYRENE
 
 
 
 
7.2.6
ENGINEERING & HIGH-PERFORMANCE PLASTICS
 
 
 
 
 
7.2.6.1
Polyether ether ketone
 
 
 
 
7.2.6.2
Nylon/polyamide
 
 
 
 
7.2.6.3
Polyphenylsulfone
 
 
 
 
7.2.6.4
Polysulfones
 
 
 
 
7.2.6.5
Polymethyl methacrylate
 
 
 
 
7.2.6.6
Polycarbonate
 
 
 
 
7.2.6.7
Acrylonitrile butadiene styrene
 
 
 
 
7.2.6.8
Other Engineering & high-performance plastics
 
 
 
7.2.7
OTHER MEDICAL PLASTICS
 
 
 
7.3
MEDICAL ELASTOMERS
 
 
 
 
 
7.3.1
FLEXIBILITY, DURABILITY, AND BIOCOMPATIBILITY TO DRIVE MARKET
 
 
 
 
7.3.2
SILICONE
 
 
 
 
7.3.3
THERMOPLASTIC ELASTOMERS
 
 
 
 
 
7.3.3.1
Thermoplastic polyurethane
 
 
 
 
7.3.3.2
Thermoplastic vulcanizates
 
 
 
 
7.3.3.3
Thermoplastic styrenic elastomers
 
 
 
 
7.3.3.4
Thermoplastic copolyester elastomers
 
 
7.4
OTHER MEDICAL ELASTOMERS
 
 
 
8
MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Kilotons | 4 Data Tables
 
 
 
98
 
8.1
INTRODUCTION
 
 
 
 
8.2
EXTRUSION TUBING
 
 
 
 
 
8.2.1
INCREASING USE IN INTRAVENOUS DELIVERY SYSTEMS, CATHETERS, AND SURGICAL INSTRUMENTS TO DRIVE MARKET
 
 
 
8.3
COMPRESSION MOLDING
 
 
 
 
 
8.3.1
INCREASING USE IN PROSTHETICS, ORTHOPEDIC IMPLANTS, AND DENTAL COMPONENTS TO DRIVE MARKET
 
 
 
8.4
INJECTION MOLDING
 
 
 
 
 
8.4.1
INCREASING USE OF SYRINGES, SURGICAL INSTRUMENTS, AND IMPLANTABLE DEVICES TO DRIVE MARKET
 
 
 
8.5
OTHER MANUFACTURING TECHNOLOGIES
 
 
 
9
MEDICAL POLYMER MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Kilotons | 4 Data Tables
 
 
 
103
 
9.1
INTRODUCTION
 
 
 
 
9.2
MEDICAL DISPOSABLES
 
 
 
 
 
9.2.1
INCREASING DEMAND FOR CATHETERS AND SYRINGES TO DRIVE MARKET
 
 
 
 
9.2.2
GLOVES
 
 
 
 
9.2.3
SYRINGES
 
 
 
 
9.2.4
MEDICAL BAGS
 
 
 
 
9.2.5
OTHER MEDICAL DISPOSABLES
 
 
 
9.3
MEDICAL INSTRUMENTS & DEVICES
 
 
 
 
 
9.3.1
INCREASING SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
 
 
 
 
9.3.2
MEDICAL TUBES
 
 
 
 
9.3.3
CATHETERS
 
 
 
 
9.3.4
DRUG DELIVERY INSTRUMENTS
 
 
 
 
9.3.5
OTHER MEDICAL INSTRUMENTS & DEVICES
 
 
 
9.4
PROSTHETICS
 
 
 
 
 
9.4.1
RISING DEMAND FOR ADVANCED LIMB PROSTHESES AND IMPLANTS TO DRIVE MARKET
 
 
 
 
9.4.2
IMPLANTS
 
 
 
 
9.4.3
LIMB PROSTHESIS
 
 
 
 
9.4.4
OTHER PROSTHETICS APPLICATIONS
 
 
 
9.5
DIAGNOSTIC INSTRUMENTS & TOOLS
 
 
 
 
 
9.5.1
INCREASING DEMAND IN SURGICAL AND PROCEDURAL APPLICATIONS TO DRIVE MARKET
 
 
 
 
9.5.2
DENTAL TOOLS
 
 
 
 
9.5.3
SURGICAL INSTRUMENTS
 
 
 
 
9.5.4
OTHER DIAGNOSTIC INSTRUMENTS & TOOLS
 
 
 
9.6
OTHER APPLICATIONS
 
 
 
10
MEDICAL POLYMER MARKET, BY REGION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Kilotons | 268 Data Tables
 
 
 
117
 
10.1
INTRODUCTION
 
 
 
 
10.2
NORTH AMERICA
 
 
 
 
 
10.2.1
US
 
 
 
 
 
10.2.1.1
High R&D investments in medical sector to drive market
 
 
 
10.2.2
CANADA
 
 
 
 
 
10.2.2.1
Emerging demand for dental implants to drive market
 
 
 
10.2.3
MEXICO
 
 
 
 
 
10.2.3.1
Expansion of manufacturing facilities to drive market
 
 
10.3
ASIA PACIFIC
 
 
 
 
 
10.3.1
CHINA
 
 
 
 
 
10.3.1.1
Establishment of medical device manufacturing units and investment in other healthcare-related sectors to drive market
 
 
 
10.3.2
INDIA
 
 
 
 
 
10.3.2.1
Rapid economic growth and growing population to drive market
 
 
 
10.3.3
SOUTH KOREA
 
 
 
 
 
10.3.3.1
Advanced healthcare and medical technologies to boost market
 
 
 
10.3.4
JAPAN
 
 
 
 
 
10.3.4.1
Developments in minimally invasive treatment and robotic surgery to support market growth
 
 
 
10.3.5
AUSTRALIA
 
 
 
 
 
10.3.5.1
Regulatory compliance and strategic collaborations to support market growth
 
 
 
10.3.6
REST OF ASIA PACIFIC
 
 
 
10.4
MIDDLE EAST & AFRICA
 
 
 
 
 
10.4.1
GCC COUNTRIES
 
 
 
 
 
10.4.1.1
Saudi Arabia
 
 
 
 
10.4.1.2
UAE
 
 
 
 
10.4.1.3
Rest of GCC
 
 
 
10.4.2
SOUTH AFRICA
 
 
 
 
 
10.4.2.1
Increased government spending on healthcare to drive market
 
 
 
10.4.3
REST OF MIDDLE EAST & AFRICA
 
 
 
10.5
EUROPE
 
 
 
 
 
10.5.1
GERMANY
 
 
 
 
 
10.5.1.1
Rising demand in dental implant application to drive market
 
 
 
10.5.2
FRANCE
 
 
 
 
 
10.5.2.1
Aging population and sedentary lifestyle to boost demand for polymers
 
 
 
10.5.3
UK
 
 
 
 
 
10.5.3.1
Growing incidences of chronic diseases and government support for innovation to drive market
 
 
 
10.5.4
ITALY
 
 
 
 
 
10.5.4.1
Strong production facilities with presence of global players to propel market growth
 
 
 
10.5.5
SPAIN
 
 
 
 
 
10.5.5.1
Surge in government funding for healthcare sector to support market
 
 
 
10.5.6
REST OF EUROPE
 
 
 
10.6
SOUTH AMERICA
 
 
 
 
 
10.6.1
BRAZIL
 
 
 
 
 
10.6.1.1
Growing aging population, expanding economy, and increasing health awareness to drive market
 
 
 
10.6.2
ARGENTINA
 
 
 
 
 
10.6.2.1
Availability of highly trained specialists and low cost of medical services boosting medical tourism industry
 
 
 
10.6.3
REST OF SOUTH AMERICA
 
 
11
COMPETITIVE LANDSCAPE
Unveil strategic insights on market leaders and emerging players reshaping the competitive landscape.
 
 
 
365
 
11.1
OVERVIEW
 
 
 
 
11.2
KEY PLAYER STRATEGIES
 
 
 
 
11.3
REVENUE ANALYSIS, 2022–2024
 
 
 
 
 
11.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
11.5
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
11.6
BRAND/PRODUCT COMPARISON ANALYSIS
 
 
 
 
 
11.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
11.7.1
STARS
 
 
 
 
11.7.2
EMERGING LEADERS
 
 
 
 
11.7.3
PERVASIVE PLAYERS
 
 
 
 
11.7.4
PARTICIPANTS
 
 
 
 
11.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
11.7.5.1
Company footprint
 
 
 
 
11.7.5.2
Region footprint
 
 
 
 
11.7.5.3
Type footprint
 
 
 
 
11.7.5.4
Application footprint
 
 
11.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
11.8.1
PROGRESSIVE COMPANIES
 
 
 
 
11.8.2
RESPONSIVE COMPANIES
 
 
 
 
11.8.3
DYNAMIC COMPANIES
 
 
 
 
11.8.4
STARTING BLOCKS
 
 
 
 
11.8.5
COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024
 
 
 
 
 
11.8.5.1
Detailed list of key startups/SMEs
 
 
 
 
11.8.5.2
Competitive benchmarking of key startups/SMEs
 
 
11.9
COMPETITIVE SCENARIO
 
 
 
 
 
11.9.1
PRODUCT LAUNCHES
 
 
 
 
11.9.2
DEALS
 
 
 
 
11.9.3
EXPANSIONS
 
 
12
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
390
 
12.1
MAJOR PLAYERS
 
 
 
 
 
12.1.1
BASF
 
 
 
 
 
12.1.1.1
Business overview
 
 
 
 
12.1.1.2
Products/Services/Solutions offered
 
 
 
 
12.1.1.3
Recent developments
 
 
 
 
12.1.1.4
MnM view
 
 
 
12.1.2
SABIC
 
 
 
 
12.1.3
COVESTRO AG
 
 
 
 
12.1.4
CELANESE CORPORATION
 
 
 
 
12.1.5
EVONIK INDUSTRIES
 
 
 
 
12.1.6
ARKEMA
 
 
 
 
12.1.7
SOLVAY
 
 
 
 
12.1.8
KURARAY CO., LTD.
 
 
 
 
12.1.9
MOMENTIVE PERFORMANCE MATERIALS INC.
 
 
 
 
12.1.10
DUPONT
 
 
 
12.2
OTHER PLAYERS
 
 
 
 
 
12.2.1
TRINSEO
 
 
 
 
12.2.2
KRATON CORPORATION
 
 
 
 
12.2.3
TOTAL PLASTICS
 
 
 
 
12.2.4
SIMONA AMERICA
 
 
 
 
12.2.5
DSM
 
 
 
 
12.2.6
INVIBIO
 
 
 
 
12.2.7
AVIENT CORPORATION
 
 
 
 
12.2.8
RTP COMPANY
 
 
 
 
12.2.9
TEKNIPLEX
 
 
 
 
12.2.10
TEKNOR APEX
 
 
 
 
12.2.11
MITSUBISHI CHEMICALS ADVANCED MATERIALS
 
 
 
 
12.2.12
WACKER CHIMIE
 
 
 
 
12.2.13
HARDIE POLYMERS
 
 
 
 
12.2.14
ELIX POLYMERS
 
 
 
 
12.2.15
INNOVATIVE POLYMER COMPOUNDS
 
 
13
APPENDIX
 
 
 
444
 
13.1
DISCUSSION GUIDE
 
 
 
 
13.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
13.3
CUSTOMIZATION OPTIONS
 
 
 
 
13.4
RELATED REPORTS
 
 
 
 
13.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
MEDICAL POLYMER MARKET: INCLUSIONS AND EXCLUSIONS
 
 
 
 
TABLE 2
MEDICAL POLYMER MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 3
PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2018–2025
 
 
 
 
TABLE 4
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS
 
 
 
 
TABLE 5
KEY BUYING CRITERIA IN MAJOR APPLICATIONS
 
 
 
 
TABLE 6
MEDICAL POLYMER MARKET: ROLE IN ECOSYSTEM
 
 
 
 
TABLE 7
GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 8
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 9
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 10
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 11
MEDICAL POLYMER MARKET: CONFERENCES & EVENTS, 2025−2026
 
 
 
 
TABLE 12
AVERAGE SELLING PRICE OF MEDICAL POLYMER, BY REGION, 2022–2024 (USD/KG)
 
 
 
 
TABLE 13
AVERAGE SELLING PRICE OF MEDICAL POLYMER OFFERED BY KEY PLAYERS, BY APPLICATION, 2024 (USD/KG)
 
 
 
 
TABLE 14
TOP 10 PATENT OWNERS, 2015–2024
 
 
 
 
TABLE 15
TABLE 1: US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
TABLE 16
MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 17
MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 18
MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 19
MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 20
MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 21
MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 22
MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 23
MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 24
MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 25
MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 26
MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 27
MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 28
MEDICAL POLYMER MARKET, BY REGION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 29
MEDICAL POLYMER MARKET, BY REGION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 30
MEDICAL POLYMER MARKET, BY REGION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 31
MEDICAL POLYMER MARKET, BY REGION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 32
NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 33
NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 34
NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 35
NORTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 36
NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 37
NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 38
NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 39
NORTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 40
NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 41
NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 42
NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 43
NORTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 44
NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 45
NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 46
NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 47
NORTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 48
US: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 49
US: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 50
US: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 51
US: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 52
US: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 53
US: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 54
US: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 55
US: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 56
CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 57
CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 58
CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 59
CANADA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 60
CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 61
CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 62
CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 63
CANADA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 64
MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 65
MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 66
MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 67
MEXICO: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 68
MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 69
MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 70
MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 71
MEXICO: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 72
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 73
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 74
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 75
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 76
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 77
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 78
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 79
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 80
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 81
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 82
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 83
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 84
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 85
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 86
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 87
ASIA PACIFIC: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 88
CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 89
CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 90
CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 91
CHINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 92
CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 93
CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 94
CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 95
CHINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 96
INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 97
INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 98
INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 99
INDIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 100
INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 101
INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 102
INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 103
INDIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 104
SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 105
SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 106
SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 107
SOUTH KOREA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 108
SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 109
SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 110
SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 111
SOUTH KOREA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 112
JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 113
JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 114
JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 115
JAPAN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 116
JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 117
JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 118
JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 119
JAPAN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 120
AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 121
AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 122
AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 123
AUSTRALIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 124
AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 125
AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 126
AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 127
AUSTRALIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 128
REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 129
REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 130
REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 131
REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 132
REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 133
REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 134
REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 135
REST OF ASIA PACIFIC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 136
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 137
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 138
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 139
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 140
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 141
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 142
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 143
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 144
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 145
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 146
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 147
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 148
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 149
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 150
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 151
MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 152
SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 153
SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 154
SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 155
SAUDI ARABIA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 156
SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 157
SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 158
SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 159
SAUDI ARABIA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 160
UAE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 161
UAE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 162
UAE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 163
UAE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 164
UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 165
UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 166
UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 167
UAE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 168
REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 169
REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 170
REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 171
REST OF GCC: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 172
REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 173
REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 174
REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 175
REST OF GCC: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 176
SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 177
SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 178
SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 179
SOUTH AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 180
SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 181
SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 182
SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 183
SOUTH AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 184
REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 185
REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 186
REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 187
REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 188
REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 189
REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 190
REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 191
REST OF MIDDLE EAST & AFRICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 192
EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 193
EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 194
EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 195
EUROPE: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 196
EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 197
EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 198
EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 199
EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 200
EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 201
EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 202
EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 203
EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 204
EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 205
EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 206
EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 207
EUROPE: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 208
GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 209
GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 210
GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 211
GERMANY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 212
GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 213
GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 214
GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 215
GERMANY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 216
FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 217
FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 218
FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 219
FRANCE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 220
FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 221
FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 222
FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 223
FRANCE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 224
UK: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 225
UK: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 226
UK: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 227
UK: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 228
UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 229
UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 230
UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 231
UK: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 232
ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 233
ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 234
ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 235
ITALY: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 236
ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 237
ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 238
ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 239
ITALY: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 240
SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 241
SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 242
SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 243
SPAIN: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 244
SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 245
SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 246
SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 247
SPAIN: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 248
REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 249
REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 250
REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 251
REST OF EUROPE: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 252
REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 253
REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 254
REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 255
REST OF EUROPE: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 256
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 257
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 258
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 259
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY COUNTRY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 260
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 261
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 262
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 263
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 264
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 265
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 266
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 267
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 268
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 269
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 270
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2022–2024 (KILOTON)
 
 
 
 
TABLE 271
SOUTH AMERICA: MEDICAL POLYMER MARKET, BY MANUFACTURING TECHNOLOGY, 2025–2030 (KILOTON)
 
 
 
 
TABLE 272
BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 273
BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 274
BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 275
BRAZIL: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 276
BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 277
BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 278
BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 279
BRAZIL: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 280
ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 281
ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 282
ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 283
ARGENTINA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 284
ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 285
ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 286
ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 287
ARGENTINA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 288
REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 289
REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 290
REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2022–2024 (KILOTON)
 
 
 
 
TABLE 291
REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY TYPE, 2025–2030 (KILOTON)
 
 
 
 
TABLE 292
REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (USD MILLION)
 
 
 
 
TABLE 293
REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (USD MILLION)
 
 
 
 
TABLE 294
REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2022–2024 (KILOTON)
 
 
 
 
TABLE 295
REST OF SOUTH AMERICA: MEDICAL POLYMER MARKET, BY APPLICATION, 2025–2030 (KILOTON)
 
 
 
 
TABLE 296
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL POLYMER MARKET BETWEEN 2021 AND 2025
 
 
 
 
TABLE 297
MEDICAL POLYMER MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 298
MEDICAL POLYMER MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 299
MEDICAL POLYMER MARKET: TYPE FOOTPRINT
 
 
 
 
TABLE 300
MEDICAL POLYMER MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 301
MEDICAL POLYMER MARKET: KEY STARTUPS/SMES
 
 
 
 
TABLE 302
MEDICAL POLYMER MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
TABLE 303
MEDICAL POLYMER MARKET: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 304
MEDICAL POLYMER MARKET: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 305
MEDICAL POLYMER MARKET: EXPANSIONS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 306
BASF: COMPANY OVERVIEW
 
 
 
 
TABLE 307
BASF: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 308
BASF: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 309
BASF: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 310
SABIC: COMPANY OVERVIEW
 
 
 
 
TABLE 311
SABIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 312
SABIC: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 313
COVESTRO AG: COMPANY OVERVIEW
 
 
 
 
TABLE 314
COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 315
COVESTRO AG: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 316
COVESTRO AG: EXPANSIONS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 317
CELANESE CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 318
CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 319
CELANESE CORPORATION: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 320
CELANESE CORPORATION: EXPANSIONS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 321
EVONIK INDUSTRIES: COMPANY OVERVIEW
 
 
 
 
TABLE 322
EVONIK INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 323
EVONIK INDUSTRIES: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 324
EVONIK INDUSTRIES: EXPANSIONS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 325
ARKEMA: COMPANY OVERVIEW
 
 
 
 
TABLE 326
ARKEMA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 327
ARKEMA: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 328
ARKEMA: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 329
ARKEMA: EXPANSIONS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 330
SOLVAY: COMPANY OVERVIEW
 
 
 
 
TABLE 331
SOLVAY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 332
KURARAY CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 333
KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 334
KURARAY CO., LTD.: EXPANSIONS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 335
MOMENTIVE PERFORMANCE MATERIALS INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 336
MOMENTIVE PERFORMANCE MATERIALS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 337
MOMENTIVE PERFORMANCE MATERIALS INC.: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 338
MOMENTIVE PERFORMANCE MATERIALS INC.: EXPANSIONS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 339
DUPONT: COMPANY OVERVIEW
 
 
 
 
TABLE 340
DUPONT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 341
DUPONT: DEALS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 342
DUPONT: EXPANSIONS, JANUARY 2021–JULY 2025
 
 
 
 
TABLE 343
TRINSEO: COMPANY OVERVIEW
 
 
 
 
TABLE 344
KRATON CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 345
TOTAL PLASTICS: COMPANY OVERVIEW
 
 
 
 
TABLE 346
SIMONA AMERICA: COMPANY OVERVIEW
 
 
 
 
TABLE 347
DSM: COMPANY OVERVIEW
 
 
 
 
TABLE 348
INVIBIO: COMPANY OVERVIEW
 
 
 
 
TABLE 349
AVIENT CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 350
RTP COMPANY: COMPANY OVERVIEW
 
 
 
 
TABLE 351
TEKNIPLEX: COMPANY OVERVIEW
 
 
 
 
TABLE 352
TEKNOR APEX: COMPANY OVERVIEW
 
 
 
 
TABLE 353
MITSUBISHI CHEMICALS ADVANCED MATERIALS: COMPANY OVERVIEW
 
 
 
 
TABLE 354
WACKER CHIMIE: COMPANY OVERVIEW
 
 
 
 
TABLE 355
HARDIE POLYMERS: COMPANY OVERVIEW
 
 
 
 
TABLE 356
ELIX POLYMERS: COMPANY OVERVIEW
 
 
 
 
TABLE 357
INNOVATIVE POLYMER COMPOUNDS: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
MEDICAL POLYMER MARKET SEGMENTATION AND REGIONAL SCOPE
 
 
 
 
FIGURE 2
MEDICAL POLYMER MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 3
MEDICAL POLYMER MARKET: BOTTOM-UP APPROACH
 
 
 
 
FIGURE 4
MEDICAL POLYMER MARKET: TOP-DOWN APPROACH
 
 
 
 
FIGURE 5
MARKET SIZE ESTIMATION: MEDICAL POLYMER MARKET TOP-DOWN APPROACH
 
 
 
 
FIGURE 6
DEMAND-SIDE FORECAST PROJECTIONS
 
 
 
 
FIGURE 7
MEDICAL POLYMER MARKET: DATA TRIANGULATION
 
 
 
 
FIGURE 8
MEDICAL PLASTICS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 9
MEDICAL INSTRUMENTS & DEVICES SEGMENT TO RECORD FASTEST GROWTH DURING FORECAST PERIOD
 
 
 
 
FIGURE 10
EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 11
ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 12
INCREASING DEMAND FROM MEDICAL INSTRUMENTS & DEVICES APPLICATION TO DRIVE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 13
MEDICAL PLASTICS SEGMENT TO LEAD MEDICAL POLYMER MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 14
MEDICAL INSTRUMENTS & DEVICES SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 15
EXTRUSION TUBING SEGMENT TO HOLD LARGEST SHARE DURING FORECAST PERIOD
 
 
 
 
FIGURE 16
INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 17
MEDICAL POLYMER MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 18
PORTER’S FIVE FORCES ANALYSIS: MEDICAL POLYMER MARKET
 
 
 
 
FIGURE 19
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR APPLICATIONS
 
 
 
 
FIGURE 20
KEY BUYING CRITERIA IN MAJOR APPLICATIONS
 
 
 
 
FIGURE 21
MEDICAL POLYMER MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 22
MEDICAL POLYMER ECOSYSTEM
 
 
 
 
FIGURE 23
MEDICAL POLYMER MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
FIGURE 24
IMPORT OF MEDICAL POLYMERS, BY COUNTRY, 2020–2024 (USD MILLION)
 
 
 
 
FIGURE 25
EXPORT OF MEDICAL POLYMERS, BY COUNTRY, 2020–2024 (USD MILLION)
 
 
 
 
FIGURE 26
AVERAGE SELLING PRICE TREND, BY REGION, 2022–2024
 
 
 
 
FIGURE 27
AVERAGE SELLING PRICE TREND, BY APPLICATION, 2022–2024
 
 
 
 
FIGURE 28
AVERAGE SELLING PRICE OFFERED BY KEY PLAYERS, BY APPLICATION, 2024
 
 
 
 
FIGURE 29
INVESTMENT AND FUNDING SCENARIO, 2019−2023 (USD MILLION)
 
 
 
 
FIGURE 32
LEGAL STATUS OF PATENTS, 2015–2024
 
 
 
 
FIGURE 35
MEDICAL PLASTICS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 36
EXTRUSION TUBING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 37
MEDICAL INSTRUMENTS & DEVICES TO HOLD LARGEST SHARE DURING FORECAST PERIOD
 
 
 
 
FIGURE 38
MEDICAL POLYMER MARKET SNAPSHOT
 
 
 
 
FIGURE 39
NORTH AMERICA: MEDICAL POLYMER MARKET SNAPSHOT
 
 
 
 
FIGURE 40
ASIA PACIFIC: MEDICAL POLYMER MARKET SNAPSHOT
 
 
 
 
FIGURE 41
EUROPE: MEDICAL POLYMER MARKET SNAPSHOT
 
 
 
 
FIGURE 42
REVENUE ANALYSIS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2022–2024
 
 
 
 
FIGURE 43
SHARES OF TOP FIVE COMPANIES IN MEDICAL POLYMER MARKET, 2024
 
 
 
 
FIGURE 44
VALUATION OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2024
 
 
 
 
FIGURE 45
FINANCIAL METRICS OF KEY COMPANIES IN MEDICAL POLYMER MARKET, 2024
 
 
 
 
FIGURE 46
MEDICAL POLYMER MARKET: BRAND/PRODUCT COMPARISON
 
 
 
 
FIGURE 47
MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 48
MEDICAL POLYMER MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 49
MEDICAL POLYMER MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 50
BASF: COMPANY SNAPSHOT
 
 
 
 
FIGURE 51
SABIC: COMPANY SNAPSHOT
 
 
 
 
FIGURE 52
COVESTRO AG: COMPANY SNAPSHOT
 
 
 
 
FIGURE 53
CELANESE CORPORATION: COMPANY SNAPSHOT
 
 
 
 
FIGURE 54
EVONIK INDUSTRIES: COMPANY SNAPSHOT
 
 
 
 
FIGURE 55
ARKEMA: COMPANY SNAPSHOT
 
 
 
 
FIGURE 56
SOLVAY: COMPANY SNAPSHOT
 
 
 
 
FIGURE 57
KURARAY CO., LTD.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 58
DUPONT: COMPANY SNAPSHOT
 
 
 
 

Methodology

The study involved four major activities for estimating the current size of the global medical polymer market. Exhaustive secondary research was conducted to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of medical polymer through primary research. Both the top-down and bottom-up approaches were employed to estimate the overall size of the medical polymer market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

In the secondary research process, various secondary sources such as Hoovers, Factiva, Bloomberg BusinessWeek, and Dun & Bradstreet were referred, to identify and collect information for this study on the medical polymer market. These secondary sources included annual reports, press releases & investor presentations of companies; white papers; certified publications; articles by recognized authors; regulatory bodies, trade directories, and databases.

Primary Research

The medical polymer market comprises several stakeholders in the supply chain, which include raw material suppliers, distributors, end-product manufacturers, buyers, and regulatory organizations. Various primary sources from the supply and demand sides of the market have been interviewed to obtain qualitative and quantitative information. The primary participants from the demand side include key opinion leaders, executives, vice presidents, and CEOs of companies in the medical polymer market. Primary sources from the supply side include associations and institutions involved in the medical polymer market, key opinion leaders, and processing players.

Following is the breakdown of interviews with experts:

Medical Polymer Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The bottom-up and top-down approaches have been used to estimate the medical polymer market by type, application, manufacturing technology, and region. The research methodology used to calculate the market size includes the following steps:

  • The key players in the industry and markets were identified through extensive secondary research.
  • In terms of value, the industry’s supply chain and market size were determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • The research included studying reports, reviews, and newsletters of top market players and extensive interviews with leaders such as directors and marketing executives to obtain opinions.

The following figure illustrates the overall market size estimation process employed for this study.

Medical Polymer Market

Data Triangulation

After arriving at the overall size of the medical polymer market from the estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

Market Definition

The medical polymer market represents the industry that develops and implements polymer materials intended for medical and healthcare purposes. In the medical sector, these polymers must adhere to strict specifications related to biocompatibility, durability, elasticity, and sterilization or aseptic requirements. Various medical products, like surgical instruments, implants, diagnostic devices, drug delivery systems, and disposables including syringes and gloves use medical polymers. The market includes many different types of polymers such as medical plastics, elastomer polymers, and biodegradable polymers. The medical polymer market is an important institutional component in the advancement of modern healthcare to enable affordable, safe, efficient medical solutions.

Stakeholders

  • Medical Polymer Manufacturers
  • Raw Material Suppliers
  • Regulatory Bodies and Government Agencies
  • Distributors and Suppliers
  • End-use Industries
  • Associations and Industrial Bodies
  • Market Research and Consulting Firms

Report Objectives

  • To define, describe, and forecast the size of the medical polymer market in terms of value and volume
  • To provide detailed information regarding the key factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To forecast the market size based on type, application, manufacturing technology, and region
  • To forecast the market size for the five main regions—North America, Europe, Asia Pacific (APAC), South America, and the Middle East & Africa (MEA),—along with their key countries
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders
  • To strategically profile leading players and comprehensively analyze their key developments, such as product launches, expansions, and deals in the medical polymer market
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To study the impact of AI/Gen AI on the market under study, along with the macroeconomic outlook

Key Questions Addressed by the Report

Which factors are propelling the growth of the medical polymer market?

Increasing demand for minimally invasive surgical procedures, technological advancements in medical devices, the rise in chronic diseases, and the expanding geriatric population requiring healthcare are the primary factors propelling the growth of the medical polymer market.

Which are the key applications driving the medical polymer market?

The key applications driving demand include medical disposables, prosthetics, medical instruments and devices, and others.

Who are the major manufacturers?

Major manufacturers include BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese Corporation (US), and Evonik Industries (Germany).

What will be the growth prospects of the medical polymer market?

The market is expected to witness robust growth due to rising global healthcare needs, advancements in polymer technology, increasing demand for biocompatible materials, and expanding applications such as drug delivery systems and implants.

What will be the growth prospects of the medical polymer market in terms of CAGR in the next five years?

The CAGR of the medical polymer market is expected to be between 8–9% over the next five years.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Medical Polymer Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Medical Polymer Market

DMCA.com Protection Status